ahlam1399
08-05-2015, 06:16 PM
Shire seen having to sweeten $30 billion offer to win Baxalta
LONDON (Reuters) – Shire Chief Executive Flemming Ornskov will need to dig deeper in his pocket if he wants to win U.S. biotech company Baxalta.
http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2.img (http://da.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/ach.img (http://adchoice.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/ach.htm)http://pi.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48bae459/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=rPYc-Q3dzIE:xzRvV_6PSQE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rPYc-Q3dzIE:xzRvV_6PSQE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=rPYc-Q3dzIE:xzRvV_6PSQE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rPYc-Q3dzIE:xzRvV_6PSQE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=rPYc-Q3dzIE:xzRvV_6PSQE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/rPYc-Q3dzIE
LONDON (Reuters) – Shire Chief Executive Flemming Ornskov will need to dig deeper in his pocket if he wants to win U.S. biotech company Baxalta.
http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2.img (http://da.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/ach.img (http://adchoice.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/ach.htm)http://pi.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234566724496/u/49/f/654207/c/35217/s/48bae459/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/48bae459/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=rPYc-Q3dzIE:xzRvV_6PSQE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rPYc-Q3dzIE:xzRvV_6PSQE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=rPYc-Q3dzIE:xzRvV_6PSQE:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=rPYc-Q3dzIE:xzRvV_6PSQE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=rPYc-Q3dzIE:xzRvV_6PSQE:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/rPYc-Q3dzIE